Reviva Pharmaceuticals Holdings - Warrants (25/12/2025) Current Cash

As of the most recent data (June 2026), RVPHW shows a current cash of $20T. That compares with $10M in the prior-year period — up 191919129.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, RVPHW's current cash is now $20T (was $10M) — a 191919129.0% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Reviva Pharmaceuticals Holdings - Warrants (25/12/2025) is outperforming or lagging.

Tracking RVPHW's current cash over time shows whether Reviva Pharmaceuticals Holdings - Warrants (25/12/2025) is scaling, shrinking, or reshaping that part of the business. The current reading is $20T That compares with $10M in the prior-year period — up 191919129.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Reviva Pharmaceuticals Holdings - Warrants (25/12/2025)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $20T) with ownership activity and broader fundamentals.

Reviva Pharmaceuticals Holdings - Warrants (25/12/2025)'s current cash is $20T; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.